OBSV - ObsEva appoints David Renas as CFO; shares +6% Premarket

ObsEva SA (OBSV) appoints David Renas as Chief Financial Officer and member of the company’s Executive Committee. He will be based in the U.S.The move is effective today.David Renas has over 30 years of financial and legal experience, including 15 years within the pharmaceutical and life sciences industry.Most recently, he served as CFO at Petra Pharma and CFO and General Counsel at Sangart, where he helped guide the company through 11 clinical trials conducted across 20 countries.Shares +6% premarket.

For further details see:

ObsEva appoints David Renas as CFO; shares +6% Premarket